HDAC9 and neoplasm: Divergent effects of therapeutic concentrations of the HDAC inhibitors SAHA and VPA on tumour cell cycle, with the former inducing a G2/M arrest and the latter inducing a G1 arrest, were reported for other tumour cell lines as well (Takai et al, 2004a, 2004b).